Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial

被引:27
|
作者
Lehmann, Ulrike [1 ]
Riedel, Annett [1 ]
Hirche, Frank [1 ]
Brandsch, Corinna [1 ]
Girndt, Matthias [2 ]
Ulrich, Christof [2 ]
Seibert, Eric [2 ]
Henning, Christian [3 ]
Glomb, Marcus A. [3 ]
Dierkes, Jutta [4 ]
Stangl, Gabriele I. [1 ]
机构
[1] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Germany
[2] Univ Halle Wittenberg, Dept Internal Med 2, Halle, Germany
[3] Univ Halle Wittenberg, Food Chem, Inst Chem, Halle, Germany
[4] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway
关键词
Vitamin D; 25(OH)D-3; 24,25(OH)(2)D-3; Supplementation; Healthy subjects; Randomized controlled trial; SERUM 25-HYDROXYVITAMIN D; GENETIC-DETERMINANTS; BIOAVAILABILITY; DIETARY; WOMEN; D-3; CALCIUM; CANCER;
D O I
10.1016/j.clnu.2015.04.021
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Large parts of the population are insufficiently supplied with vitamin D, in particular when endogenous synthesis is absent. Therefore many health care providers recommend the use of vitamin D supplements. The current study aimed to investigate the efficacy of an once-daily oral dose of 20 mu g vitamin D-3 to improve the vitamin D status and to evaluate predictors of response. Methods: The study was conducted as a double-blind, randomized, placebo-controlled parallel trial from January till April 2013. In total, 105 subjects (2-71 years) were allocated to receive either a vitamin D-3 supplement (20 mu g/d) or a placebo for 12 weeks. Circulating levels of vitamin D-3 metabolites such as the 25(OH)D-3 and the 24,25(OH)(2)D-3, and biomarkers of calcium and phosphate metabolism were quantified. Results: The 25(OH)D-3 serum concentrations in the placebo group decreased from 38 +/- 15 nmol/L at baseline to 32 +/- 14 nmol/L and 32 +/- 13 nmol/L at weeks 8 and 12 of the study, respectively (p < 0.01). In the vitamin D-3 group, the serum 25(OH)D-3 concentration increased from 38 +/- 14 nmol/L at baseline to 70 +/- 15 nmol/L and 73 +/- 16 nmol/L at weeks 8 and 12 of vitamin D-3 supplementation (p < 0.001), respectively. As a result, 94% of the vitamin D-3-supplemented participants reached 25(OH)D-3 concentrations of >= 50 nmol/L and thereof 46% attained 25(OH)D-3 levels of >= 75 nmol/L until the end of the study. The extent of the 25(OH)D-3 increase upon vitamin D-3 supplementation depended on 25(OH)D-3 baseline levels, age, body weight and circulating levels of triglycerides. In contrast to 25(OH)D-3, the response of 24,25(OH)(2)D-3 to the vitamin D-3 treatment was affected only by baseline levels of 24,25(OH)(2)D-3 and age. Conclusions: The average improvement of 25(OH)D-3 levels in individuals who received 20 mu g vitamin D-3 per day during the winter months was 41 nmol/L compared to individuals without supplementation. As a result almost all participants with the vitamin D-3 supplementation attained 25(OH)D-3 concentrations of 50 nmol/L and higher. The suitability of 24,25(OH)(2)D-3 as a marker of vitamin D status needs further investigation. (C) 2015 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:351 / 358
页数:8
相关论文
共 50 条
  • [31] The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial
    Lise Sofie Bislev
    Lene Langagergaard Rødbro
    Jesper Nørgaard Bech
    Erling Bjerregaard Pedersen
    Alisa D. Kjaergaard
    Søren Andreas Ladefoged
    Lars Rolighed
    Tanja Sikjaer
    Lars Rejnmark
    Endocrine, 2018, 62 : 182 - 194
  • [32] The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial
    Bislev, Lise Sofie
    Rodbro, Lene Langagergaard
    Bech, Jesper Norgaard
    Pedersen, Erling Bjerregaard
    Kjaergaard, Alisa D.
    Ladefoged, Soren Andreas
    Rolighed, Lars
    Sikjaer, Tanja
    Rejnmark, Lars
    ENDOCRINE, 2018, 62 (01) : 182 - 194
  • [33] Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial
    Raed, Anas
    Bhagatwala, Jigar
    Zhu, Haidong
    Pollock, Norman K.
    Parikh, Samip J.
    Huang, Ying
    Havens, Robyn
    Kotak, Ishita
    Guo, De-Huang
    Dong, Yanbin
    PLOS ONE, 2017, 12 (12):
  • [34] Is a daily supplementation with 40 microgram vitamin D3 sufficient? A randomised controlled trial
    Toss, Goran
    Magnusson, Per
    EUROPEAN JOURNAL OF NUTRITION, 2012, 51 (08) : 939 - 945
  • [35] Is a daily supplementation with 40 microgram vitamin D3 sufficient? A randomised controlled trial
    Göran Toss
    Per Magnusson
    European Journal of Nutrition, 2012, 51 : 939 - 945
  • [36] Vitamin D and Vitamin D3 Supplementation during Photodynamic Therapy: A Review
    Mazur, Anna
    Koziorowska, Katarzyna
    Dynarowicz, Klaudia
    Aebisher, David
    Bartusik-Aebisher, Dorota
    NUTRIENTS, 2022, 14 (18)
  • [37] Vitamin D3 (D3) supplementation in subjects with primary hyperparathyroidism (PHPT): evaluation of safety and biochemical response
    Pallone, Sthefanie Giovanna
    Ohe, Monique Nakayama
    Santos, Livia Marcela
    Nacaguma, Isabela Ohki
    Costa Silva, Renata Elen
    Kunii, Ilda Sizue
    Vieira, Jose Gilberto
    Lazaretti-Castro, Marise
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 50 - 50
  • [38] Supplementation of Vitamin D3 (Cholecalciferol) in Patients With Ulcerative Colitis and Hypovitaminosis D: A Prospective Randomized Trial
    Mathur, Jagrati
    Mills, Paul
    Naing, Soe
    Limsui, David
    GASTROENTEROLOGY, 2014, 146 (05) : S454 - S454
  • [39] Vitamin D3, the "Sunshine" Vitamin
    Saljoughian, Manouchehr
    US PHARMACIST, 2011, 36 (04) : HS28 - HS32
  • [40] Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial
    Martineau, Adrian R.
    Thummel, Kenneth E.
    Wang, Zhican
    Jolliffe, David A.
    Boucher, Barbara J.
    Griffin, Simon J.
    Forouhi, Nita G.
    Hitman, Graham A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (12): : 5831 - 5839